ANGO vs TXN · rev $292.5M vs P/E 52, rev $17.68B
AngioDynamics Inc (ANGO) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported TXN revenue for 2025-12-31 was $17.68B. Net income was $5.00B. Revenue was up 13.0% from 2024-12-31 to 2025-12-31. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
ANGO currently screens at market cap $378.5M. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the ANGO and TXN stock pages for the full models.
Not investment advice.